• Home
  • Search Results

Search Results

432 studies match your search
By physician referral or invitation only

Nodify XL2 Biomarker Blood Draw Study

Patients will undergo a blood draw for a gene classifier test. Some patients will have their physicians informed of the result, and another group of patients will be randomized to be managed by standard of care. Qualifying patients have incidentally identified lung nodules assessed as < 50% risk of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
  • Lungs and Breathing
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

PharmFIT

This is a study to assess patient, provider, and pharmacist perceptions of delivering FIT kits for colorectal cancer screening in pharmacy settings.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Prostate cancer care with or without gene testing

This project is a randomized clinical trial (study that randomly assigns participants to one arm to fairly understand outcomes) that aims to assess if information from gene expression classifier (GEC) testing is helpful for both patients and their doctors in the management of care for newly diagnosed prostate cancer patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Gender Inclusive
Study Interest
  • Cancer (Prostate)
  • Men's Health
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Systemic inflammatory responses to cryosurgery and prostatectomy for treatment of prostate cancer

You are being asked to participate in this study because you have an appointment at UNC Urology, and you have been diagnosed with prostate cancer. The purpose of this research study is to learn how either cryosurgery or prostatectomy procedures change the inflammatory response within the body. To do this, we will draw blood and analyze it for signs of inflammation before and after your standard of care procedure.

Age & Gender
  • 40 years ~ 99 years
  • Male, Gender Inclusive
Study Interest
  • Cancer (Prostate)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Symptom Management Assessment in Cancer Patients in Malawi

We are working to translate and validate a survey that looks at symptom management and quality of life for patients in Malawi getting palliative care treatment to make sure that the survey is applicable, relatable, and understandable for these patients.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Promoting Clinical Trials in African Americans with Pancreatic Cancer

This study seeks to promote clinical trial engagement in African Americans with pancreatic cancer. The first group of people will be interviewed by phone to discuss clinical trials. This information will be used to create a new mobile health app/website. In the second group, half of the participants will receive the new app and half will not. They will both be asked to complete questionnaires after their upcoming doctor visits.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pancreatic)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Southeastern Consortium for Lung Cancer Health Equity

To initiate and evaluate a multilevel navigation intervention to promote lung cancer screening among Black/African Americans and to develop a population-based biorepository for future research in understanding biological risk factors for poor lung cancer outcomes among Black/African Americans

Age & Gender
  • 50 years ~ 80 years
  • Male, Female
Study Interest
  • Cancer (Lung)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

A study to see if memantine protects the brain during radiation therapy treatment for a brain tumor

The purpose of this study is to to determine the efficacy (as measured by Neurocognitive testing) of oral memantine administered for a period of 6 months, when compared to placebo, in children ages 4-18 receiving cranial or craniospinal radiotherapy for primary central nervous system tumors.

Age & Gender
  • 4 years ~ 17.99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
  • Cancer (Brain and Other Nervous System, Pediatric Cancers)
  • Child and Teen Health
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Brain slice explants to predict drug response in brain tumors

You are being asked to participate in this research study because you have a type of tumor called a Central Nervous System (CNS) tumor, and you are scheduled to have surgery to remove this tumor. The study team wants to use left-over tumor samples from this surgery to study your tumor and test new ways to fight it.

Age & Gender
  • 0 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

AMC-114 - Paclitaxel or Liposomal Doxorubicin for HIV-positive Persons with Kaposi Sarcoma

This study is being done to answer the following question: Do two different anti-cancer drugs, paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) have similar effects on treating KS in PLWH in sub-Saharan Africa? We are doing this study because we want to find out if one of these approaches, PTX or PLD, is better than the other for KS. Both drugs may be given as part of the usual approach for your KS. The usual approach is defined as care most people get for KS.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Sarcoma (bone and soft tissue))
  • HIV/AIDS
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research